SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C. 20549

                                FORM 8-K
                             CURRENT REPORT

                    Pursuant to Section 13 or 15(d) of 
                   the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported):  July 9, 1996


                        COPLEY PHARMACEUTICAL, INC.
          (Exact name of registrant as specified in its charter)


                                Delaware
      (State or other jurisdiction of incorporation or organization) 




              0-20126                             04-2514637
      (Commission File Number)         (IRS Employer Identification No.)



             25 John Road
         Canton, Massachusetts                          02021
(Address of principal executive offices)             (Zip Code)

 

                          (617) 821-6111
        (Registrant's telephone number, including area code)




<PAGE 2>


Item 5.	Other Events

     On July 9, 1996, Copley Pharmaceutical, Inc. (the "Company") announced
 that Kenneth N. Larsen will assume the office of President on an interim
 basis in place of Dr. Gabriel R. Cipau, who has resigned all positions in
 the Company, as well as a member to the Board of Directors, to pursue other
 career interests.

     Mr. Larsen has been a member of the Company's Board of Directors since
 1989, and currently serves as its Chairman, and also served as a member of
 the Board from September 1985 to November 1986. A well-known consultant and
 advisor to numerous health-care companies from 1989 to the present, Mr.
 Larsen was also a founding member and initial chairman of the Generic
 Pharmaceutical Industry Association.


	




<PAGE 3>

                             SIGNATURES 



 Pursuant to the requirements of the Securities Exchange Act of 1934, the
 Registrant has duly caused this report to be signed on its behalf by the
 undersigned hereunto duly authorized.

                                                                    
July 30, 1996                                               

COPLEY PHARMACEUTICAL, INC.

   /s/ Kenneth N. Larsen   
 ______________________________
       Kenneth N. Larsen 
     President and Chairman
[{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 2275}]
{"company-data": {"conformed-name": "COPLEY PHARMACEUTICAL INC", "cik": "0000829987", "assigned-sic": "2834", "irs-number": "042514637", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-20126", "film-number": "96600885"}, "business-address": {"street1": "25 JOHN RD ST 13TH FL", "city": "CANTON", "state": "MA", "zip": "02021", "phone": "6178216111"}}
SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C. 20549

                                FORM 8-K
                             CURRENT REPORT

                    Pursuant to Section 13 or 15(d) of 
                   the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported):  July 9, 1996

                        COPLEY PHARMACEUTICAL, INC.
          (Exact name of registrant as specified in its charter)

                                Delaware
      (State or other jurisdiction of incorporation or organization) 

              0-20126                             04-2514637
      (Commission File Number)         (IRS Employer Identification No.)

             25 John Road
         Canton, Massachusetts                          02021
(Address of principal executive offices)             (Zip Code)

 

                          (617) 821-6111
        (Registrant's telephone number, including area code)
Item 5.	Other Events

     On July 9, 1996, Copley Pharmaceutical, Inc. (the "Company") announced
 that Kenneth N. Larsen will assume the office of President on an interim
 basis in place of Dr. Gabriel R. Cipau, who has resigned all positions in
 the Company, as well as a member to the Board of Directors, to pursue other
 career interests.

     Mr. Larsen has been a member of the Company's Board of Directors since
 1989, and currently serves as its Chairman, and also served as a member of
 the Board from September 1985 to November 1986. A well-known consultant and
 advisor to numerous health-care companies from 1989 to the present, Mr.
 Larsen was also a founding member and initial chairman of the Generic
 Pharmaceutical Industry Association.
SIGNATURES 

 Pursuant to the requirements of the Securities Exchange Act of 1934, the
 Registrant has duly caused this report to be signed on its behalf by the
 undersigned hereunto duly authorized.

                                                                    
July 30, 1996                                               

COPLEY PHARMACEUTICAL, INC.

   /s/ Kenneth N. Larsen   
 ______________________________
       Kenneth N. Larsen 
     President and Chairman